Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Dermatology

Free Subscription 09.02.2026 5 Am J Dermatopathol 1 Am J Ophthalmol 1 Am J Pathol 3 BMC Cancer 8 Br J Dermatol 2 Cancer 3 Cancer Res 1 Clin Dermatol 17 Clin Exp Dermatol 2 Cutis 10 Eur J Dermatol 4 Int J Cancer 14 Int J Dermatol 1 Intern Med 10 J Cutan Pathol 22 J Dermatol 7 J Invest Dermatol 1 J Laryngol Otol 1 Lancet 1 Plast Reconstr Surg 1 PLoS Comput Biol 1 PLoS Med 4 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. COLBERT MD, Holder K, Tekin B, Buonaccorsi JN, et al
   A Case of Malignant Melanoma With Numerous Wagner-Meissner-Like Bodies.
   Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003240.
   PubMed         Abstract available
   
   
2. RUSSOLILLO JK, Schaedler A, Hsia B, Silberstein PT, et al
   Comprehensive Genomic Profiling of Acral Melanoma: Insights From the AACR Project GENIE Database.
   Am J Dermatopathol. 2026 Feb 6. doi: 10.1097/DAD.0000000000003237.
   PubMed         Abstract available
   
   
3. DILEEP A, Cloutier JM, Green DC, Mann JA, et al
   Blue-Black Dome-Shaped Papule on the Right Upper Back of a 12-Year-Old Child: Challenge.
   Am J Dermatopathol. 2026;48:e13-e14.
   PubMed        
   
   
4. DILEEP A, Cloutier JM, Green DC, Mann JA, et al
   Blue-Black Dome-Shaped Papule on the Right Upper Back of a 12-Year-Old Child: Answer.
   Am J Dermatopathol. 2026;48:155-156.
   PubMed        
   
   
5. HAIDUK II, Valkov AY
   Cutaneous Epithelioid Myxofibrosarcoma Arising in a Face: Case Report and Literature Review.
   Am J Dermatopathol. 2025 Dec 15. doi: 10.1097/DAD.0000000000003189.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

6. VAISMAN D, Pe'er J, Eiger-Moscovich M, Lotem M, et al
   Interferon Alpha-2a as Treatment for Primary Acquired Melanosis with Atypia (PAMwA) and for PAMwA surrounding conjunctival melanoma.
   Am J Ophthalmol. 2026 Jan 29:S0002-9394(26)00042.
   PubMed         Abstract available
   
   

   
   Am J Pathol

7. SHEETS AR, McNamee SM, Lian CG, Murphy GF, et al
   Dermal Microvascular Responses of Human IPSC-Derived Skin Organoids to Inflammation and Injury.
   Am J Pathol. 2026 Feb 2:S0002-9440(26)00030-1. doi: 10.1016/j.ajpath.2026.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. HUNDAL J, Williams D, Nock NL, Austin K, et al
   Older breast cancer survivors' exercise and support group program experiences and recommendations from the IMPROVE trial: a qualitative study.
   BMC Cancer. 2026 Jan 6. doi: 10.1186/s12885-025-15425.
   PubMed         Abstract available
   
   
9. LV M, Liu Y, Cao W, Wang Y, et al
   Identification of RPGRIP1L as an instability-maintaining gene to drive tumor growth and PD-L1 expression via Hedgehog signaling in breast cancer.
   BMC Cancer. 2025 Dec 30. doi: 10.1186/s12885-025-15500.
   PubMed         Abstract available
   
   
10. ZHAO M, Zhao L, Yang Y, Wang F, et al
    Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.
    BMC Cancer. 2026;26:139.
    PubMed        
    
    

    
    Br J Dermatol

11. LIU Y, Ge J, Xu G, Cai C, et al
    Burden and Risk of Asthma and Rhinitis in Atopic Dermatitis: Global Estimates from a Hierarchical Bayesian Model.
    Br J Dermatol. 2026 Feb 5:ljag025. doi: 10.1093.
    PubMed         Abstract available
    
    
12. YUANBO Z, Huishu L, Qianyang Z, Yaping H, et al
    Spatial Proteomics Reveals Layer-Specific Molecular Landscapes and KRT17-Mediated Inflammatory Crosstalk in Tongue Oral Lichen Planus.
    Br J Dermatol. 2026 Feb 5:ljag040. doi: 10.1093.
    PubMed         Abstract available
    
    
13. GAN X, Wu Y, Sun X, Zhao A, et al
    Chimeric antigen receptor T-cell therapy for relapsed/refractory primary cutaneous B-lymphoblastic lymphoma with rapid and durable systemic regression.
    Br J Dermatol. 2025 Dec 2:ljaf484. doi: 10.1093.
    PubMed        
    
    
14. O'REILLY P, Fortune DG, Ingen-Housz-Oro S, Hannigan A, et al
    Development of a health-related quality of life outcome measure for adults with Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) - QoLTEN: An international multidisciplinary DELPHI consensus survey.
    Br J Dermatol. 2026 Feb 3:ljag037. doi: 10.1093.
    PubMed        
    
    
15. BEAGLES E, Khattab S, Burke OM, Nguyen N, et al
    The Impact of Clinicopathologic Features on the Prognosis of Thin Melanomas: A Retrospective Cohort Analysis.
    Br J Dermatol. 2026 Feb 2:ljag034. doi: 10.1093.
    PubMed         Abstract available
    
    
16. PICARDO M, Chen Q
    Metabolic approach to counteract skin aging.
    Br J Dermatol. 2026 Jan 29:ljag026. doi: 10.1093.
    PubMed        
    
    
17. QI J, Nie G
    Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden'.
    Br J Dermatol. 2026 Jan 28:ljag030. doi: 10.1093.
    PubMed        
    
    
18. BRIGHT HRB, Smith CH, Laws P, Reynolds NJ, et al
    Serious infection risk in people treated with infliximab for severe psoriasis.
    Br J Dermatol. 2026 Jan 28:ljag032. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

19. MA Y, Li X, Jiang Y, Xiao L, et al
    The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta-analysis.
    Cancer. 2026;132:e70268.
    PubMed         Abstract available
    
    
20. LAWRENCE L
    Nine-year data show sustained benefit of nivolumab in patients with high-risk resected melanoma.
    Cancer. 2026;132:e70234.
    PubMed        
    
    

    
    Cancer Res

21. CHENG Y, Huang G, Liu X, Wu C, et al
    Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.
    Cancer Res. 2025 Dec 4:OF1-OF18. doi: 10.1158/0008-5472.CAN-25-0261.
    PubMed         Abstract available
    
    
22. BONECHI F, Bacci M, Lorito N, Smiriglia A, et al
    ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.
    Cancer Res. 2025 Nov 7. doi: 10.1158/0008-5472.CAN-25-1339.
    PubMed         Abstract available
    
    
23. BERENS EB, Khou S, Huang ET, Hoffman A, et al
    Neoplastic Immune Mimicry Potentiates Breast Tumor Progression.
    Cancer Res. 2026;86:587-603.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

24. MA S, Zieneldien T, Aljassabi A, Grant-Kels JM, et al
    Reframing Psoriasis Therapy: TYK2 Inhibition and the Erosion of the Oral-Biologic Divide.
    Clin Dermatol. 2026 Jan 21:S0738-081X(26)00008.
    PubMed        
    
    

    
    Clin Exp Dermatol

25. CHIONG T, Koh MJA, Gan EY
    A Rare Paediatric Case of Linear and Annular Lupus Panniculitis of the Scalp.
    Clin Exp Dermatol. 2026 Feb 5:llag068. doi: 10.1093.
    PubMed        
    
    
26. AL-SHARBATEE G, Daruish M, Ng V, Foot O, et al
    Multiple yellow papules arising within previously irradiated breast skin.
    Clin Exp Dermatol. 2026 Feb 5:llag065. doi: 10.1093.
    PubMed        
    
    
27. LAU LDW, Narula M, Haggett M, Kok Y, et al
    Disseminated classic Kaposi Sarcoma.
    Clin Exp Dermatol. 2026 Feb 5:llag064. doi: 10.1093.
    PubMed        
    
    
28. KREFT S, Green AC, Lorigan P
    Regional melanoma incidence rates a decade after UV output inspections of commercial sunbeds in England.
    Clin Exp Dermatol. 2026 Feb 3:llag026. doi: 10.1093.
    PubMed        
    
    
29. VAIOPOULOS AG, Katsimbri P, Lazarou-Athanasopoulou V, Tzavara C, et al
    Real-World Efficacy and Safety of Ixekizumab from the Joint Psoriasis-Psoriatic Arthritis Clinic (PPAC).
    Clin Exp Dermatol. 2026 Feb 3:llag055. doi: 10.1093.
    PubMed         Abstract available
    
    
30. KIM Y, Tan DYL, Bewley A, Mohandas P, et al
    Time to reconsider blood monitoring guidance: A retrospective review of psoriasis patients requiring discontinuation of biological therapy from a multi-site NHS trust.
    Clin Exp Dermatol. 2026 Feb 3:llag058. doi: 10.1093.
    PubMed        
    
    
31. SOHAIL N, Sohail A, Alsaidi A, Zamil D, et al
    Non-Tobacco Nicotine Dependence and Rates of Postoperative Complications in Basal Cell Carcinoma: A Retrospective Analysis.
    Clin Exp Dermatol. 2026 Jan 31:llag060. doi: 10.1093.
    PubMed        
    
    
32. SUN L, Ge H
    Medical Management of Primary Cutaneous Mucormycosis Caused by Mucor irregularis with Oral Itraconazole in a Type 1 Diabetic Patient: a case report.
    Clin Exp Dermatol. 2026 Jan 29:llag046. doi: 10.1093.
    PubMed        
    
    
33. AMAGATA Y, Saito-Sasaki N, Okada E, Sawada Y, et al
    Aggressive Amelanotic Melanoma in a Patient with Oculocutaneous Albinism Type 1A: A Case with Limited Response to Targeted and Immunotherapy.
    Clin Exp Dermatol. 2026 Jan 28:llag042. doi: 10.1093.
    PubMed        
    
    
34. QI J, Nie G
    Comment on 'Nail Matrix Melanoma in Adolescents and Young Adults': Shifting the Diagnostic Paradigm: Replacing "Adult Age" with "After Puberty" for Earlier Detection.
    Clin Exp Dermatol. 2026 Jan 27:llag039. doi: 10.1093.
    PubMed        
    
    
35. DAS A, Dutta B, Padovese V, Hay RJ, et al
    The Changing Face of Dermatophytosis: from common skin disease to emerging resistant epidemic.
    Clin Exp Dermatol. 2026 Jan 23:llag034. doi: 10.1093.
    PubMed         Abstract available
    
    
36. BRUFAU-COCHS M, Gomez-Martinez S, Aya F, Serra-Garcia L, et al
    Pembrolizumab Therapy Leads to Lentigines Resolution and Tumour Control in a Xeroderma Pigmentosum patient with Advanced Cutaneous Squamous Cell Carcinoma.
    Clin Exp Dermatol. 2026 Jan 22:llag029. doi: 10.1093.
    PubMed        
    
    
37. BONGIOVANNI E, Santaniello U, Astrua C, Cavaliere G, et al
    Managing Metastatic Cutaneous Squamous Cell Carcinoma in VEXAS Syndrome: A Therapeutic Challenge.
    Clin Exp Dermatol. 2026 Jan 23:llag032. doi: 10.1093.
    PubMed        
    
    
38. GANATRA B, Hall-Craggs M, Younis I, Ellery P, et al
    Progressive limb induration and skin tightening.
    Clin Exp Dermatol. 2026 Jan 22:llaf554. doi: 10.1093.
    PubMed        
    
    
39. ALENEZY K, Williams L, Ailenei E, Oyewale N, et al
    Umbilical Cutaneous Endometriosis: A Diagnostic Challenge.
    Clin Exp Dermatol. 2026 Jan 22:llag028. doi: 10.1093.
    PubMed        
    
    
40. QIN J, Deng J, Zou Y
    Comment on "Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years": clarifying drug survival metrics and capturing joint outcomes.
    Clin Exp Dermatol. 2026 Jan 19:llag024. doi: 10.1093.
    PubMed        
    
    
41. POTLURU A, Nikookam Y
    Expanding the Dermatologic Horizon of GLP-1 Receptor Agonists - Response to 'Dermatologic and Metabolic Benefits of Semaglutide in Psoriasis with Obesity: A Six-Month Prospective Cohort Study'.
    Clin Exp Dermatol. 2026 Jan 19:llag025. doi: 10.1093.
    PubMed        
    
    

    
    Cutis

42. RANESES E, Kramer K, Schmidgal C
    Solitary Yellow Papule on the Upper Back in an Infant.
    Cutis. 2025;116:204-210.
    PubMed        
    
    
43. EZE AN, Usatine RP, Heath CR
    Early Infantile Hemangioma Diagnosis Is Key in Skin of Color.
    Cutis. 2025;116:223-224.
    PubMed        
    
    

    
    Eur J Dermatol

44. SUNDARAM H, Zhou J, Marti M, Thibaut S, et al
    A novel framework for integrative hair longevity management.
    Eur J Dermatol. 2026;36.
    PubMed         Abstract available
    
    
45. PIRACCINI BM, Dias MFG, Abraham LS, Rudnicka L, et al
    Androgenetic alopecia: an international expert view on the aetiopathogenesis, quality of life and current and emerging therapeutic approaches.
    Eur J Dermatol. 2026;36.
    PubMed         Abstract available
    
    
46. ALMEIDA-SILVA G, Antunes J, Filipe P
    sQUIZ your knowledge! Asymptomatic purplish papules on the limbs of a 16-year-old female.
    Eur J Dermatol. 2025;35:574-575.
    PubMed        
    
    
47. LOPEZ-VERA E, Rodriguez-Moncada JS, Gomez-Moyano E
    sQUIZ your knowledge! Itchy papules in a 68-year-old woman.
    Eur J Dermatol. 2025;35:570-571.
    PubMed        
    
    
48. GASPARINI G, Amber KT, Li J, Bao L, et al
    Antigen-presenting cell phenotype of skin-infiltrating eosinophils in bullous pemphigoid patients.
    Eur J Dermatol. 2025;35:551-554.
    PubMed        
    
    
49. JIANG Y, Song X, Wang Y
    Recurrent neurological blisters restricted to the upper limbs: cutaneous alert of syringomyelia.
    Eur J Dermatol. 2025;35:550-551.
    PubMed        
    
    
50. NAGATANI K, Tsunoda T
    Tamoxifen-induced vasculitis mimicking cutaneous arteritis.
    Eur J Dermatol. 2025;35:541-543.
    PubMed        
    
    
51. KOBAYASHI T, Iinuma S, Ishida-Yamamoto A
    Dabrafenib-induced panniculitis with interface dermatitis in a patient with thyroid carcinoma.
    Eur J Dermatol. 2025;35:540-541.
    PubMed        
    
    
52. NAKAZAWA A, Ansai S, Umebayashi Y
    Granular cell fibrous papule: a case report.
    Eur J Dermatol. 2025;35:531-532.
    PubMed        
    
    
53. BORIK-HEIL L, Holler C, Bohler K, Brunner M, et al
    Successful adjuvant nivolumab therapy in a toddler with xeroderma pigmentosum and stage III melanoma.
    Eur J Dermatol. 2025;35:529-531.
    PubMed        
    
    

    
    Int J Cancer

54. HAJIRAHIMKHAN A, Bartom ET, Chung CH, Guo X, et al
    Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer prevention.
    Int J Cancer. 2026;158:1927-1940.
    PubMed         Abstract available
    
    
55. ANDOUR L, Kroep JR, Putter H, Tollenaar RAEM, et al
    Neoadjuvant endocrine therapy often leads to breast and axilla-conserving surgery in stages II and III hormone receptor-positive breast cancer patients: A registry study.
    Int J Cancer. 2025 Nov 4. doi: 10.1002/ijc.70219.
    PubMed         Abstract available
    
    
56. TUNBEKICI S, Sahin G, On S, Oruc A, et al
    Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group.
    Int J Cancer. 2025 Oct 28. doi: 10.1002/ijc.70213.
    PubMed         Abstract available
    
    
57. CHEPTEA C, Loap P, Allali S, Fourquet A, et al
    Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group.
    Int J Cancer. 2025 Oct 11. doi: 10.1002/ijc.70190.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

58. SUN QW, Damsky WE, Cohen JM
    Cost Consequences Associated With Biologic Therapy Switching in Publicly Insured Psoriasis Individuals in the United States.
    Int J Dermatol. 2026 Feb 6. doi: 10.1111/ijd.70325.
    PubMed        
    
    
59. BARNAWI G, Lazarowitz R, Aly S, Nukaly H, et al
    Mohs Surgery Outcomes for Basal Cell Carcinoma Treated With Neoadjuvant Sonic Hedgehog Inhibitor.
    Int J Dermatol. 2026 Feb 6. doi: 10.1111/ijd.70304.
    PubMed        
    
    
60. ALAM Z, Nguyen KT, Goldstein DR, Raman J, et al
    Amplified Skin Cancer Risk in HPV-Positive Immunosuppressed Patients: A Multicenter Real-World Cohort Study.
    Int J Dermatol. 2026 Feb 6. doi: 10.1111/ijd.70331.
    PubMed        
    
    
61. NIFOROU A, Lagiou P, Geller AC, Dessypris N, et al
    Exogenous Hormone Use and Breslow Thickness in Women With Cutaneous Melanoma: A Retrospective Cohort Study.
    Int J Dermatol. 2026 Jan 29. doi: 10.1111/ijd.70321.
    PubMed         Abstract available
    
    
62. GAUMOND SI, Mufarrej S, Angioli AM, Abdin R, et al
    Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20-Year Descriptive Study.
    Int J Dermatol. 2026 Jan 29. doi: 10.1111/ijd.70306.
    PubMed         Abstract available
    
    
63. SZEPIETOWSKA M, Krajewski PK, Pacan P, Wojas-Pelc A, et al
    The Psychiatric Comorbidities in Adolescents With Atopic Dermatitis: A Real-World Study of Propensity-Matched Cohorts.
    Int J Dermatol. 2026 Jan 27. doi: 10.1111/ijd.70301.
    PubMed         Abstract available
    
    
64. BESTAVROS S, Geng RSQ, Donovan J
    Frontal Fibrosing Alopecia and Its Association With Genital Lichen Planus and Lichen Sclerosus: A Systematic Review.
    Int J Dermatol. 2026 Jan 24. doi: 10.1111/ijd.70287.
    PubMed        
    
    
65. TALASILA S, Nadir U, Jeha GM, Tolkachjov SN, et al
    Diagnostic Implications of Dupilumab-Refractory Atopic Dermatitis: Risk of Underlying Cutaneous T-Cell Lymphoma and the Role of Skin Biopsy.
    Int J Dermatol. 2026 Jan 23. doi: 10.1111/ijd.70307.
    PubMed        
    
    
66. HERCENT A, Borgel A, Lamoril J, Grange F, et al
    CYLD Cutaneous Syndrome: Report of a New Splicing Pathogenic Variant and Additional Evidence Supporting the Absence of Genotype-Phenotype Correlation.
    Int J Dermatol. 2026 Jan 22. doi: 10.1111/ijd.70312.
    PubMed        
    
    
67. SCHELLIN D, Rosing S, Zimmermann N, Leuchten N, et al
    Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus.
    Int J Dermatol. 2026 Jan 22. doi: 10.1111/ijd.70251.
    PubMed         Abstract available
    
    
68. STENGER K, Zimmerman HM, Karagenova R, Liao L, et al
    Delayed Diagnosis of Disseminated Cutaneous Mycobacterium chelonae: A Diagnostic Pitfall in Immunosuppressed Patients.
    Int J Dermatol. 2026 Jan 21. doi: 10.1111/ijd.70297.
    PubMed        
    
    
69. HE S, Zhan Z, Zhang Y, Fang X, et al
    Eruptive Melanocytic Nevi Associated With Olverembatinib Therapy.
    Int J Dermatol. 2026 Jan 18. doi: 10.1111/ijd.70243.
    PubMed        
    
    
70. NAZZICONE K, Dahlke E, Head L, Herzinger T, et al
    Exploring What Constitutes a Good-Quality Referral for a Potentially Malignant Skin Lesion: A Modified Delphi Consensus.
    Int J Dermatol. 2026 Jan 18. doi: 10.1111/ijd.70300.
    PubMed        
    
    
71. FOERSTER Y, Palaras J, Mayer K, Biedermann T, et al
    Sirolimus for Secondary Prevention of Cutaneous Squamous Cell Carcinoma in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Int J Dermatol. 2026 Jan 17. doi: 10.1111/ijd.70285.
    PubMed         Abstract available
    
    

    
    Intern Med

72. KAWAKAMI Y, Inoue A, Kato J, Nakase H, et al
    Cutaneous Lesions of IgG4-related Disease.
    Intern Med. 2026 Feb 1. doi: 10.2169/internalmedicine.6721.
    PubMed        
    
    

    
    J Cutan Pathol

73. SINGH AP, Obiorah IE
    An Unusual Case of Primary Mucocutaneous Cytotoxic T-Cell Lymphoma With Epidermotropism and Phenotype Switch: Diagnostic and Molecular Insights.
    J Cutan Pathol. 2026;53:263-269.
    PubMed         Abstract available
    
    
74. ALONSO-MTZ DE SALINAS L, Ruiz-Iglesias C, Hernandez-Alfonso J, Hernandez-Calle D, et al
    Follicular Becker's Nevus: Clinical, Dermoscopic and Histopathological Description of Two Cases and Literature Review.
    J Cutan Pathol. 2026;53:254-257.
    PubMed         Abstract available
    
    
75. CASADO GL, Xu E, Haymete MA, Ramey NA, et al
    What the Eyelid Can Tell You: The Unexpected Initial Presentation of De Novo Stage IV Breast Carcinoma.
    J Cutan Pathol. 2026;53:248-253.
    PubMed         Abstract available
    
    
76. NAHARRO MJ, Rojas N, Gegundez H, Monteagudo C, et al
    Evidence for Wnt/beta-Catenin-Activated Rosette-Forming Carcinoma Arising in Rb-Inactivated Bowen Disease.
    J Cutan Pathol. 2026;53:230-236.
    PubMed         Abstract available
    
    
77. LANG HOUSER M, Mancuso JB, Gudjonsson JE, Hristov AC, et al
    Mycoplasma pneumoniae-Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases.
    J Cutan Pathol. 2026;53:276-283.
    PubMed         Abstract available
    
    
78. SARI M, Schliep S, Petzold A, Kiesewetter F, et al
    Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach.
    J Cutan Pathol. 2026 Feb 5. doi: 10.1111/cup.70064.
    PubMed         Abstract available
    
    
79. AGUERA-SANCHEZ A, Del Carmen Brufau-Redondo M, Poblet E
    Whipple's Disease: Panniculitis Among Other Dermatoses. A Case Report and Literature Review.
    J Cutan Pathol. 2026 Feb 3. doi: 10.1111/cup.70066.
    PubMed         Abstract available
    
    
80. CHAUDHARY S, Fan J, Obiorah IE
    Primary Cutaneous Peripheral T-Cell Lymphoma With TFH Phenotype With Divergent Clonal B- and Plasma-Cell Populations and DNMT3A Mutation.
    J Cutan Pathol. 2026 Jan 29. doi: 10.1111/cup.70065.
    PubMed         Abstract available
    
    
81. OSMAN KM, Prok L, Wisell JA, Ma Y, et al
    Pediatric Acral Melanoma With a Novel ARL6IP1-PRKCB Fusion.
    J Cutan Pathol. 2026 Jan 28. doi: 10.1111/cup.70063.
    PubMed        
    
    
82. SINA N, Muhaj F, Lenskaya V, Ivan D, et al
    Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients.
    J Cutan Pathol. 2026 Jan 18. doi: 10.1111/cup.70060.
    PubMed         Abstract available
    
    

    
    J Dermatol

83. XIANG W, Luo H, Song D, Zhang X, et al
    Novel POLR3A Gene Mutation Results in Wiedemann-Rautenstrauch Syndrome With Striking Cutis Laxa and Myelofibrosis.
    J Dermatol. 2026;53:357-361.
    PubMed         Abstract available
    
    
84. SOUZA BCE, Miyashiro D, Cury-Martins J, Valente NYS, et al
    Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides.
    J Dermatol. 2026;53:304-308.
    PubMed         Abstract available
    
    
85. BETTOLINI L, Maronese CA, Bighetti S, Genovese G, et al
    Amicrobial Pustulosis of the Folds Successfully Treated With Apremilast: Report of Two Cases and Review of the Literature.
    J Dermatol. 2026;53:339-350.
    PubMed         Abstract available
    
    
86. ZHENG Y, Zhu Y, Qiao J
    Generalized Linear Porokeratosis Treated With Ixekizumab.
    J Dermatol. 2026;53:e146-e148.
    PubMed         Abstract available
    
    
87. LIN YH, Wang YC, Chen TL, Jaun LC, et al
    Association Between Prurigo Nodularis and Malignancy: A Real-World Multicenter Retrospective Cohort Study.
    J Dermatol. 2026;53:281-287.
    PubMed         Abstract available
    
    
88. OGAWA S, Tayama J, Kamudoni P, Salek S, et al
    Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index.
    J Dermatol. 2026;53:210-218.
    PubMed         Abstract available
    
    
89. OHYACHI K, Takamura S, Iino K, Saito S, et al
    Sex Differences in Response and Persistence to Biologic Therapy in Psoriatic Arthritis: A 52-Week Analysis With Extended Long-Term Outcomes.
    J Dermatol. 2026;53:219-230.
    PubMed         Abstract available
    
    
90. OCHIAI S, Ono H, Shimizu A, Togi S, et al
    A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene.
    J Dermatol. 2026;53:314-317.
    PubMed         Abstract available
    
    
91. INOUE S
    Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk.
    J Dermatol. 2026;53:188-199.
    PubMed         Abstract available
    
    
92. KOHRI N, Yatsuzuka K, Ishii N, Yoshida S, et al
    Tear Fluid Indirect Immunofluorescence for Assessing Disease Activity in Ocular Mucous Membrane Pemphigoid: First Report of a New Method for Monitoring Disease Progression.
    J Dermatol. 2026;53:334-338.
    PubMed         Abstract available
    
    
93. CHIEOSILAPATHAM P, Youngchim S, Chongkae S, Tovanabutra N, et al
    Atypical Presentation of Rupioid-Like Tinea Corporis due to a Rare Nannizzia Incurvata Infection.
    J Dermatol. 2026;53:323-329.
    PubMed         Abstract available
    
    
94. UEDA K, Sumigama A, Watanabe N, Kodama D, et al
    A Case of Endocrine Mucin-Producing Sweat Gland Carcinoma Which Recurred 8 Years After Excision, and Exhibited Infiltrative Growth Pattern Without Any Mucinous Carcinoma.
    J Dermatol. 2026;53:330-333.
    PubMed         Abstract available
    
    
95. OISO N, Mizoro Y, Kamei K, Yamanaka K, et al
    Health-Related Quality of Life and Psychological Burden of Patients With Vitiligo in Japan.
    J Dermatol. 2026;53:200-209.
    PubMed         Abstract available
    
    
96. KURODA Y, Yang L, Katayama I
    Pathogenesis of Chemical Leukoderma and Chemical-Induced Vitiligo.
    J Dermatol. 2026;53:180-187.
    PubMed         Abstract available
    
    
97. CHEN H, Hou PC, Hsu SH, Huang HY, et al
    Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role.
    J Dermatol. 2026;53:245-252.
    PubMed         Abstract available
    
    
98. OKAMURA K, Suzuki T
    Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical Manifestations.
    J Dermatol. 2026;53:169-179.
    PubMed         Abstract available
    
    
99. KATOH N
    The Pathogenesis of Atopic Dermatitis-Trends for the Future.
    J Dermatol. 2026 Feb 3. doi: 10.1111/1346-8138.70164.
    PubMed        
    
    
100. WATANABE H, Kawashima S, Yoshino K, Matsuzawa T, et al
     A Case of Melanoma of the Glans With BRAF(V600E) Mutation Successfully Treated With Dabrafenib and Trametinib.
     J Dermatol. 2026 Feb 2. doi: 10.1111/1346-8138.70167.
     PubMed        
     
     
101. TANAKA R, Hiki K, Sato T, Mashiko R, et al
     Treatment Beyond Progressive Disease With Pazopanib for Cutaneous Angiosarcoma: A Case Report.
     J Dermatol. 2026 Feb 2. doi: 10.1111/1346-8138.70165.
     PubMed        
     
     
102. ONISHI S, Yasutomi Y, Tsedendorj O, Morizane S, et al
     Cytokine Milieu Relevant to Atopic Dermatitis Enhances Epidermal Trypsin-Like Serine Protease Activity, Which Is Pharmacologically Suppressed in Human Keratinocytes.
     J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70160.
     PubMed        
     
     
103. OKADA-JOKAKU M, Ohara Y, Kido C, Watanabe K, et al
     Effectiveness of Combinational Therapy With Tapinarof and Narrowband Ultraviolet B for Atopic Dermatitis.
     J Dermatol. 2026 Jan 27. doi: 10.1111/1346-8138.70158.
     PubMed        
     
     
104. MATSUMOTO S, Watanabe H, Saito R, Moriwaki M, et al
     A Case of Multiple Recalcitrant Verruca Vulgaris Associated With Atopic Dermatitis Successfully Treated With Nemolizumab and Topical Imiquimod.
     J Dermatol. 2026 Jan 18. doi: 10.1111/1346-8138.70145.
     PubMed        
     
     

     
     J Invest Dermatol

105. XIAO F, Wu R, Wu N, Xie Y, et al
     Fat mass and obesity-associated (FTO)/SOCS6-m(6)A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
     J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00068.
     PubMed         Abstract available
     
     
106. RAWAL D, Lee WJ, Shim WS
     Azelaic acid potentiates TRPV3 activity as a mechanism for skin irritation.
     J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00071.
     PubMed        
     
     
107. DI GIROLAMO D, Di Cicco E, Miro C, Murolo M, et al
     Thyroid hormone inactivation sustains cancer stem cell maintenance and tumorigenesis in basal cell carcinoma.
     J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00074.
     PubMed         Abstract available
     
     
108. SIMPSON CL
     Leveraging gene-edited cells in organotypic models to discover therapeutic strategies for orphan skin diseases.
     J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00072.
     PubMed        
     
     
109. KAWAI T, Hayashi R, Hasegawa A, Sato H, et al
     Pre-eradication fecal Helicobacter pylori antigen levels as a predictive marker for skin eruption during eradication therapy.
     J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00031.
     PubMed        
     
     
110. XIE F, Xie Y, Liu J
     Botulinum Neurotoxin Type A1 Alleviates Bleomycin-induced Skin Fibrosis by Inhibiting PI3K-Akt Pathway and Associated Cell Cycle and Proliferation.
     J Invest Dermatol. 2026 Jan 23:S0022-202X(26)00030.
     PubMed         Abstract available
     
     
111. DUBRAC S, Combarros D, Olah A, Cadiergues MC, et al
     Recommendations on in vitro models for canine atopic dermatitis.
     J Invest Dermatol. 2026 Jan 20:S0022-202X(25)03668.
     PubMed        
     
     

     
     J Laryngol Otol

112. PETRELLI F, Dal Cin E, Carioli D, Gasparini A, et al
     High-Risk Cutaneous Squamous Cell Carcinoma: A Review of Current Evidence and Emerging Standards.
     J Laryngol Otol. 2026 Jan 19:1-27. doi: 10.1017/S0022215126104332.
     PubMed        
     
     

     
     Lancet

113. GOMMERS J, Hernstrom V, Josefsson V, Sartor H, et al
     Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy tria
     Lancet. 2026;407:505-514.
     PubMed         Abstract available
     
     

     
     Plast Reconstr Surg

114. CHANG EI
     Discussion: Enhancing Skin Regeneration during Expansion: A Multicenter Randomized Controlled Trial of Stromal Vascular Fraction and Fat Grafting.
     Plast Reconstr Surg. 2026;157:372-373.
     PubMed        
     
     

     
     PLoS Comput Biol

115. JI T, Yang B, Wang M, Ji H, et al
     AugGCL: Multimodal graph learning for spatial transcriptomics analysis with enhanced gene and morphological data.
     PLoS Comput Biol. 2026;22:e1013912.
     PubMed         Abstract available
     
     

     
     PLoS Med

116. NOTINI G, Bianchini G, Perez-Garcia JM, Cortes J, et al
     Beyond the hype: Antibody-Drug Conjugates are advancing faster than our clinical strategy.
     PLoS Med. 2026;23:e1004930.
     PubMed         Abstract available
     
     

     
     PLoS One

117. CAZAGRANDA IC, de Almeida RF, Smaniotto LL, de Andrade Berny MP, et al
     Hidden risks associated with occupational pesticide exposure in women with breast cancer: High frequency of the Luminal B molecular subtype and occurrence of poor prognostic features.
     PLoS One. 2026;21:e0339471.
     PubMed         Abstract available
     
     
118. YANG F, Xia Q, Wu M, Hu H, et al
     Identification of common genes and biomarkers between Dermatomyositis and rheumatoid arthritis through integrated bioinformatics.
     PLoS One. 2026;21:e0340617.
     PubMed         Abstract available
     
     
119. MOHAMMAD HUSSIN N, Nik Jaafar NR, Idris IB, Mohammed Nawi A, et al
     Mental health help-seeking among individuals with breast cancer: A qualitative exploration of women's and healthcare practitioners' perspectives.
     PLoS One. 2026;21:e0342002.
     PubMed         Abstract available
     
     
120. STINTON S, Edwick D, Maxwell-Smith C, Bear N, et al
     Evaluating the effect of the SMART intervention in people with recently diagnosed breast cancer who are being treated at a public tertiary hospital in Australia: protocol and statistical analysis plan for a single-blinded, single centre randomised con
     PLoS One. 2026;21:e0341423.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

121. ROJAS-JIMENEZ E, Bui TM, Yan P, Li Z, et al
     Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancer.
     Proc Natl Acad Sci U S A. 2026;123:e2501052123.
     PubMed         Abstract available
     
     
122. SERRA M, Rediti M, Collet L, Lifrange F, et al
     Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.
     Proc Natl Acad Sci U S A. 2026;123:e2517567123.
     PubMed         Abstract available
     
     
123. NADAV-ELIYAHU S, Bohrer C, Boocholez A, Kinor N, et al
     Nuclear speckles are regulatory hubs for viral and host mRNA expression during HSV-1 infection.
     Proc Natl Acad Sci U S A. 2026;123:e2511555123.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum